Completed NA INTERVENTIONAL 2-arm NCT01223742

Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy

ORAL ACETYL-L-CARNITINE THERAPY REDUCES FATIGUE IN HEPATIC ENCEPHALOPATHY

Sponsor: University of Catania

Interventions ACETYL-L-CARNITINE placebo

Updated 4 times since 2017 Last updated: Oct 18, 2010 Started: Jun 30, 2002 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hepatic Encephalopathy and is currently completed. University of Catania leads this study, which shows 4 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Catania

Data source: University of Catania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catania, Italy